|
TMEM60 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.670000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.511600E-01 |
| Normal-vs-Stage2 |
3.262400E-01 |
| Normal-vs-Stage3 |
9.836200E-01 |
| Normal-vs-Stage4 |
1.944110E-02 |
| Stage1-vs-Stage2 |
5.305000E-01 |
| Stage1-vs-Stage3 |
4.561800E-01 |
| Stage1-vs-Stage4 |
4.748400E-02 |
| Stage2-vs-Stage3 |
2.900800E-01 |
| Stage2-vs-Stage4 |
3.984200E-01 |
| Stage3-vs-Stage4 |
1.607860E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.685380E-01 |
| Normal-vs-AfricanAmerican |
5.406000E-01 |
| Normal-vs-Asian |
3.956000E-01 |
| Caucasian-vs-AfricanAmerican |
1.049600E-01 |
| Caucasian-vs-Asian |
2.929000E-01 |
| AfricanAmerican-vs-Asian |
6.436000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.756000E-01 |
| Normal-vs-Female |
3.664400E-01 |
| Male-vs-Female |
9.374800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.243830E-01 |
| Normal-vs-Age(41-60Yrs) |
2.488800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.514000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.443400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.097200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.259000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.010000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.676000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.566600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.743800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.142200E-01 |
| Normal-vs-Grade 2 |
2.155400E-01 |
| Normal-vs-Grade 3 |
2.272200E-01 |
| Normal-vs-Grade 4 |
8.886000E-01 |
| Grade 1-vs-Grade 2 |
6.375900E-02 |
| Grade 1-vs-Grade 3 |
1.212780E-01 |
| Grade 1-vs-Grade 4 |
3.578600E-01 |
| Grade 2-vs-Grade 3 |
9.414200E-01 |
| Grade 2-vs-Grade 4 |
2.545800E-01 |
| Grade 3-vs-Grade 4 |
2.604400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.010500E-02 |
| Normal-vs-ccB subtype |
8.573400E-01 |
| ccA subtype-vs-ccB subtype |
1.083540E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.560960E-01 |
| Normal-vs-N1 |
4.646200E-01 |
| N0-vs-N1 |
7.166600E-01 |
|
|
